vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $75.5M, roughly 1.7× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -4.8%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
PBYI vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $124.7M |
| Net Profit | — | $1.9M |
| Gross Margin | 69.3% | 24.3% |
| Operating Margin | 22.7% | 3.3% |
| Net Margin | — | 1.5% |
| Revenue YoY | 27.7% | -3.9% |
| Net Profit YoY | — | -53.6% |
| EPS (diluted) | $0.26 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $124.7M | ||
| Q3 25 | $54.5M | $85.1M | ||
| Q2 25 | $52.4M | $140.8M | ||
| Q1 25 | $46.0M | $115.9M | ||
| Q4 24 | $59.1M | $129.7M | ||
| Q3 24 | $80.5M | $88.3M | ||
| Q2 24 | $47.1M | $159.1M | ||
| Q1 24 | $43.8M | $137.5M |
| Q4 25 | — | $1.9M | ||
| Q3 25 | $8.8M | $-3.4M | ||
| Q2 25 | $5.9M | $8.6M | ||
| Q1 25 | $3.0M | $2.1M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $20.3M | $-1.9M | ||
| Q2 24 | $-4.5M | $27.9M | ||
| Q1 24 | $-4.8M | $7.9M |
| Q4 25 | 69.3% | 24.3% | ||
| Q3 25 | 77.7% | 25.9% | ||
| Q2 25 | 76.5% | 28.8% | ||
| Q1 25 | 77.1% | 24.1% | ||
| Q4 24 | 76.4% | 26.6% | ||
| Q3 24 | 63.9% | 27.4% | ||
| Q2 24 | 77.4% | 35.5% | ||
| Q1 24 | 75.5% | 28.7% |
| Q4 25 | 22.7% | 3.3% | ||
| Q3 25 | 17.6% | -3.5% | ||
| Q2 25 | 12.7% | 9.3% | ||
| Q1 25 | 8.7% | 4.1% | ||
| Q4 24 | 22.6% | 5.8% | ||
| Q3 24 | 27.4% | -1.7% | ||
| Q2 24 | -4.6% | 17.4% | ||
| Q1 24 | -5.3% | 8.2% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | 16.2% | -4.0% | ||
| Q2 25 | 11.2% | 6.1% | ||
| Q1 25 | 6.5% | 1.8% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 25.2% | -2.1% | ||
| Q2 24 | -9.6% | 17.5% | ||
| Q1 24 | -11.0% | 5.7% |
| Q4 25 | $0.26 | $0.04 | ||
| Q3 25 | $0.17 | $-0.08 | ||
| Q2 25 | $0.12 | $0.19 | ||
| Q1 25 | $0.06 | $0.05 | ||
| Q4 24 | $0.40 | $0.10 | ||
| Q3 24 | $0.41 | $-0.04 | ||
| Q2 24 | $-0.09 | $0.60 | ||
| Q1 24 | $-0.10 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $22.4M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $363.2M |
| Total Assets | $216.3M | $548.6M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $22.4M | ||
| Q3 25 | $94.4M | $18.0M | ||
| Q2 25 | $96.0M | $25.2M | ||
| Q1 25 | $93.2M | $26.7M | ||
| Q4 24 | $101.0M | $39.1M | ||
| Q3 24 | $96.7M | $35.5M | ||
| Q2 24 | $96.8M | $60.8M | ||
| Q1 24 | $107.2M | $47.4M |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $363.2M | ||
| Q3 25 | $115.3M | $364.4M | ||
| Q2 25 | $104.7M | $372.5M | ||
| Q1 25 | $97.1M | $366.9M | ||
| Q4 24 | $92.1M | $371.5M | ||
| Q3 24 | $71.1M | $380.0M | ||
| Q2 24 | $48.5M | $399.9M | ||
| Q1 24 | $51.0M | $376.4M |
| Q4 25 | $216.3M | $548.6M | ||
| Q3 25 | $202.9M | $554.6M | ||
| Q2 25 | $194.9M | $559.6M | ||
| Q1 25 | $196.2M | $578.9M | ||
| Q4 24 | $213.3M | $587.4M | ||
| Q3 24 | $220.7M | $571.3M | ||
| Q2 24 | $205.0M | $577.4M | ||
| Q1 24 | $214.1M | $570.6M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $27.3M |
| Free Cash FlowOCF − Capex | $14.4M | $16.3M |
| FCF MarginFCF / Revenue | 19.1% | 13.1% |
| Capex IntensityCapex / Revenue | 0.0% | 8.8% |
| Cash ConversionOCF / Net Profit | — | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $27.3M | ||
| Q3 25 | $9.7M | $-8.1M | ||
| Q2 25 | $14.1M | $40.8M | ||
| Q1 25 | $3.6M | $-9.8M | ||
| Q4 24 | $15.6M | $-7.4M | ||
| Q3 24 | $11.0M | $-30.8M | ||
| Q2 24 | $1.0M | $43.7M | ||
| Q1 24 | $11.2M | $25.2M |
| Q4 25 | $14.4M | $16.3M | ||
| Q3 25 | $9.7M | $-12.4M | ||
| Q2 25 | $14.1M | $33.5M | ||
| Q1 25 | $3.6M | $-16.1M | ||
| Q4 24 | $15.6M | $-10.7M | ||
| Q3 24 | $11.0M | $-35.5M | ||
| Q2 24 | $1.0M | $38.2M | ||
| Q1 24 | — | $7.0M |
| Q4 25 | 19.1% | 13.1% | ||
| Q3 25 | 17.7% | -14.6% | ||
| Q2 25 | 26.8% | 23.8% | ||
| Q1 25 | 7.7% | -13.9% | ||
| Q4 24 | 26.4% | -8.3% | ||
| Q3 24 | 13.7% | -40.2% | ||
| Q2 24 | 2.1% | 24.0% | ||
| Q1 24 | — | 5.1% |
| Q4 25 | 0.0% | 8.8% | ||
| Q3 25 | 0.0% | 5.0% | ||
| Q2 25 | 0.0% | 5.2% | ||
| Q1 25 | 0.1% | 5.4% | ||
| Q4 24 | 0.0% | 2.5% | ||
| Q3 24 | 0.0% | 5.3% | ||
| Q2 24 | 0.0% | 3.5% | ||
| Q1 24 | 0.0% | 13.2% |
| Q4 25 | — | 14.22× | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 4.73× | ||
| Q1 25 | 1.21× | -4.68× | ||
| Q4 24 | — | -1.63× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
